Over the past decade, universal health coverage (UHC) has emerged as a major policy goal for many low- and middle-income country governments. Yet, despite the high burden of cardiovascular diseases (CVD), relatively little is known about how to address CVD through UHC. This review covers three major topics. First, we define UHC and provide some context for its importance, and then we illustrate its relevance to CVD prevention and treatment. Second, we discuss how countries might select high-priority CVD interventions for a UHC health benefits package drawing on economic evaluation methods. Third, we explore some implementation challenges and identify research gaps that, if addressed, could improve the inclusion of CVD into UHC.
- QUALITY OF CARE AND OUTCOMES
Statistics from Altmetric.com
Contributors DAW conceived the study, gathered the literature and wrote the first draft. RAN reviewed the literature and revised the draft for important intellectual content.
Competing interests DAW and RAN are supported by the Disease Control Priorities Network grant from the Bill and Melinda Gates Foundation to the University of Washington. Additionally, DAW is funded by Medtronic Foundation through support to Rheumatic heart disease Evidence-Advocacy-Communication-Hope (RhEACH) and RHD Action, and RAN is funded by RTI International.
Provenance and peer review Commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.